Key result
The female secretory pattern of growth hormone specifically upregulated FAS and GPAT expression in rat liver, an effect associated with decreased insulin sensitivity.
Why the study?
Does the sexually dimorphic secretory pattern of growth hormone regulate hepatic gene expression of SREBP-1c and its target genes in rats?
Does the sexually dimorphic secretory pattern of growth hormone regulate hepatic gene expression of SREBP-1c and its target genes in rats?
The female secretory pattern of growth hormone specifically upregulates FAS and GPAT in rat liver, an effect associated with decreased insulin sensitivity rather than direct action on hepatocytes.
Hypothesis-generating for GH pattern effects on hepatic insulin sensitivity in rats; leaves open human relevance.
We investigated whether the sexually dimorphic secretory pattern of growth hormone (GH) in the rat regulates hepatic gene expression of sterol regulatory element-binding protein-1c (SREBP-1c) and its target genes. SREBP-1c, fatty acid synthase (FAS), and glycerol-3-phosphate acyltransferase (GPAT) mRNA were more abundant in female than in male livers, whereas acetyl-CoA carboxylase-1 (ACC1) and stearoyl-CoA desaturase-1 (SCD-1) were similarly expressed in both sexes. Hypophysectomized female rats were given GH as a continuous infusion or as two daily injections for 7 days to mimic the female- and male-specific GH secretory patterns, respectively. The female pattern of GH administration increased the expression of SREBP-1c, ACC1, FAS, SCD-1, and GPAT mRNA, whereas the male pattern of GH administration increased only SCD-1 mRNA. FAS and SCD-1 protein levels were regulated in a similar manner by GH. Incubation of primary rat hepatocytes with GH increased SCD-1 mRNA levels and decreased FAS and GPAT mRNA levels but had no effect on SREBP-1c mRNA. GH decreased hepatic liver X receptor-alpha (LXRalpha) mRNA levels both in vivo and in vitro. Feminization of the GH plasma pattern in male rats by administration of GH as a continuous infusion decreased insulin sensitivity and increased expression of FAS and GPAT mRNA but had no effect on SREBP-1c, ACC1, SCD-1, or LXRalpha mRNA. In conclusion, FAS and GPAT are specifically upregulated by the female secretory pattern of GH. This regulation is not a direct effect of GH on hepatocytes and does not involve changed expression of SREBP-1c or LXRalpha mRNA but is associated with decreased insulin sensitivity.
No takes yet. Share an insight, caveat, or question.
Améen et al. (2004) studied this question. Growth hormone (continuous infusion vs daily injections) vs. Male pattern GH (two daily injections) or baseline was evaluated on Hepatic gene expression of SREBP-1c and target genes (FAS, GPAT, ACC1, SCD-1). The female secretory pattern of growth hormone specifically upregulated FAS and GPAT expression in rat liver, an effect associated with decreased insulin sensitivity.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: